Français
English
Españolmenstrual pain
 |
Matricaria recutita(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf and flower, infusion, orally4 |
Recommandations
Preparation and posology References |
According to published and other information: Use for colic, diarrhea, stomach pain and expulsion of placenta is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. For diarrhea, the use of this plant can be considered complementary to oral re-hydration therapy. Should there be a notable worsening of the patient’s condition, or should the colic, diarrhea or stomach pain last more than 3 days, seek medical attention. The pollen is potentially allergenic and may induce reactions of hypersensitivity in susceptible individuals or those with prior allergy to Asteraceae (esp. ragweed and Chrysanthemum).
|
For menstrual pain and stomach pain: Prepare an infusion adding 250 mL (1 cup) of boiling water to 3 grams of dried flower. Cover pot, leave to settle for 5-10 minutes and filter. Drink one cup between meals, 3-4 times a day32-33. There is no available information about preparation and dosage of the decoction of the entire plant, the infusion of the leaf, or the infusion of the leaf and flower, other than that referred to by traditional use. |
1 RAUSCHERT S, 1974 Nomenklatorische Probleme in der Gattung Matricaria L. Folia Geobot Phytotax Praha 9:249-260. 2 LAGOS-WITTE S, 1988-89, 1996 Encuesta TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Dep. de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 3 GOMEZ H, GAITAN R, DIAZ F, 2003 Encuesta TRAMIL (Norte del departamento de Bolívar). Grupo de Productos Naturales, Facultad de Ciencias Químicas y Farmacéuticas. Universidad de Cartagena, Cartagena de Indias, Colombia. 4 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 5 FRANZ C, WICKEL I, 1980 Contribution to the heredity of bisaboloids in Chamomilla recutita. (abstract). Planta Med 39:287-288. 6 SALAMON I, 1992 Production of chamomile, Chamomilla recutita (L.) Rauschert, in Slovakia. J Herbs Spices Med Plants 1(1/2):37-45. 7 MANCHENO MN, 1987 La manzanilla dentro del plan terapéutico de tratamiento de la enfermedad diarreica aguda del Ministerio de Salud. Nicaragua. Rescate de la Medicina Popular Tradicional. 8 MERICLI AH, 1990 The lypophilic compounds of a Turkish Matricaria chamomilla variety with no chamazulene in the volatile oil. Int J Crude Drug Res 28(2):145-147. 9 TOPOLOV V, GABROLOV M, YANKOLOV J, 1983 Plantas medicinales and fitoterapia (Bilki and Bilcosvirane). Plovdiv, Bulgaria: Ed. Jristo G. Danov. 10 MORON F, FURONES J, PINEDO Z, 1996 Actividad espasmolítica del extracto fluído de Matricaria recutita (Manzanilla) en órganos aislados. Rev Cubana Plant Med 1(1):19-24. 11 CAMBAR P, 1992 Efectos broncopulmonares de los extractos acuosos de flores de Matricaria chamomilla L. (Manzanilla) en conejos. Informe TRAMIL. Unidad de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 12 ABDUL-GHANI AS, EL-LATI SG, SACAAN AI, SULEIMAN MS, AMIN RM, 1987 Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Res 25(1):39-43. 13 HOERHAMMER L, 1962 Flavone concentration of medicinal plants with regard to their spasmolytic action. Congr Sci Farm Conf Commun 21st Pisa 1961(21):578-588. 14 JAKOVLEV V, ISAAC O, FLASKAMP E, 1983 Pharmacologische Untersuchungen von Kamillen-Inhaltsstoffen. VI. Untersuchungen zur antiphlogistiche Wirkung von Chamazulen und Matricin. Planta Med 49:67-73. 15 YAMAZAKI M, SHIROTA H, 1981 Application of experimental stress ulcer test in mice for the survey of neurotropic naturally occurring drug materials. Shoyakugaku Zasshi 35:96-102. 16 GERSHEBIN LL, 1977 Regeneration of rat liver in the presence of essential oils and their components. Food Cosmet Toxicol 15(3):173-182. 17 ITOKAWA H, MIHASHI S, WATANABE K, NATSUMOTO H, HAMANAKA T, 1983 Studies on the constituents of crude drugs having inhibitory activity against contraction of the ileum caused by histamine or barium chloride (I). Screening test for the activity of commercially available crude drugs and the related plant materials. Shoyakugaku Zasshi 37(3):223-228. 18 LESLIE GB, 1978 A pharmacometric evaluation of nine bio-strath herbal remedies. Medita 8(10):3-19. 19 SZELENYI I, ISSAC O, THIEMER K, 1979 Pharmakologische Untersuchungen von Kamillen-inhaltsstoffen. III. Tierexperimentelle Untersuchungen uber die ulkusprotektive Wirkung der Kamille. Planta Med 35:218-227. 20 SHIPOCHLIEV T, 1981 Uterotonic action of extract from a group of medicinal plants. Vett Med Nauki 18(4):94-98. 21 ACHTERRATH-TUCKERMANN U, KUNDE R, FLASKAMP E, ISAAC O, THIEMER K, 1980 Pharmacological investigations with compounds of chamomile. V. Investigations on the spasmolytic effect of compounds of chamomile and Kamillosan on the isolated guinea pig ileum. Planta Med 39(1):38-50. 22 AGGAG ME, YOUSEF RT, 1972 Study of antimicrobial activity of chamomile oil. Planta Med 22(2):140-144. 23 MANN C, STABA E, 1986 The chemistry, pharmacology and commercial formulations of chamomile. In: Herbs, spices and medicinal plants; recent advances in botany, horticulture and pharmacology. Phoenix, USA: Oryxpress 1:235-280. 24 ISAAC O, 1979 Pharmacological investigations with compounds of chamomile I. On the pharmacology of alfa-bisabolol and bisabolol oxides (review). Planta Med 35:118-124. 25 JAKOVLEV V, SCHLICHTEGROLL A, 1969 Antiinflammatory activity of (-)-alpha-bisabolol, an essential component of chamomille oil. Arzneim-Forsch 19:615. 26 AL-HINDAWI M, AL-DEEN I, NABI M, ISMAIL M, 1989 Antiinflamatory activity of some Iraqi plants using intact rats. J Ethnopharmacol 26(2):163-168. 27 LESLIE G, SALMON G, 1979 Repeated dose toxicity studies and reproductive studies on nine bio-strath herbal remedies. Swiss Med 1(1/2):1-3. 28 BENNER MH, LEE HJ, 1973 Anaphylactic reaction to chamomille tea. J Allergy Clin Immunol 52(5):307-308. 29 LEWIS R, TATKEN R, (Eds.), 1980 Registry of toxic effects of chemical substances. Vol. 1. Cincinnati, USA: Nat. Instit. Occupational Health. 30 OPDYKE D, 1974 Monographs on fragrance raw materials. Chamomile oil German and Roman. Food Cosmet Toxicol 12(Suppl.):851-853. 31 ANON (Select Committee on GRAS Substances), 1976 GRAS status of foods and food additives. Washington, USA: Food and Drug Administration, Department of Health and Human Services, Office of the Federal Register National Archives and Records Administration 41, 38644. 32 WICHTL M, 1994 Herbal drugs and phytopharmaceuticals. Stuttgart, Germany: Medpharm GmbH Scientific Publisher. 33 GIRON L, CACERES A, FREIRE V, ALONZO A, SALVADOR L, 1995 Folleto informativo sobre algunas plantas medicinales comúnmente utilizadas por la población Garifuna de Livingston. Guatemala, Guatemala: Programa TRAMIL-Centroamérica/enda-caribe/CONAPLAMED/FARMAYA/CIID. p37. 34 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, MORON F, 2005 Clases tóxicas agudas (CTA) de decocción de flor seca de Matricaria recutita L. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 35 LOPEZ M, MARTINEZ MJ, MOREJON Z, BOUCOURT E, FERRADA C, FUENTES V, MORON F, 2005 Irritabilidad dérmica primaria de una decocción de flor seca de Matricaria recutita L. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Medicina “Dr. Salvador Allende”, Cerro, C. Habana, Cuba. 36 GarcIa-GONZÁLEZ M, BolaÑos An, arguedas cr, 2005 Efecto analgésico en ratas, por vía oral,del extracto acuoso (decocción) de la planta entera sin flor de Matricaria recutita dosis única. Informe TRAMIL.PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 37 GarcIa-GONZÁLEZ M, Arguedas R, y Fernández A, 2005 Efecto antiinflamatorio en ratas, por vía oral, del extracto acuoso (decocción) de la planta entera sin flor de Matricaria recutita dosis única. Informe TRAMIL.PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. |
|
 |
Sphagneticola trilobata(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys aerial parts, decoction or infusion, orally2 |
Recommandations
Preparation and posology References |
According to published and other information: Use for bronchitis is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. Uses for menstrual pain and vomiting are classified as REC, based on the significant traditional use (OMS/WHO)4 documented in the TRAMIL surveys. |
For bronchitis, menstrual pain and vomiting: There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 OCAMPO R, 1988 2 MARCELLE G, 1996 3 BENEDETTI MD, 1994 4 WHO, 1991 5 BOHLMANN F, ZIESCHE J, KING RM, ROBINSON H, 1981 6 BOHLMANN F, NGO LE VAN, 1977 7 CRAVEIRO AA, MATOS FJA, ALENCAR JW, MACHADO MIL, KRUSH A, SILVA MGV, 1993 8 KOHEIL MA, 2000 9 CÁCERES A, GONZÁLEZ S, GIRÓN L, 1998 10 CÁCERES A, GONZÁLEZ S, GIRÓN L, 2000 11 GARCÍA GM, COTO MT, GONZÁLEZ CS, PAZOS L, 1999 12 PAZOS L, COTO T, GONZÁLEZ S, QUIROS S, 2003 13 GARCÍA GM, COTO MT, GONZÁLEZ CS, OCAMPO R, PAZOS L, 2001 14 HERRERA J, 1992 15 GOH CL, 1986 |